Ingredion Inc (INGR): Results of Operations and Financial Condition
Ingredion Inc (INGR) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE Ingredion Incorporated CONTACTS: 5 Westbrook Corporate Center Investors: Noah Weiss, 773-896-5242 Westchester, IL 60154 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS SECOND QUARTER 2026 RESULTS • Second quarter 2026 reported and adjusted* operating i
How this was made
The 30-second read
Why it matters
Traders can update models for FY EPS ranges and reassess deal completion probability given Tate & Lyle shareholder approval, while also monitoring segment-level margin and volume drivers cited in the release.
Market read
2Q26 EPS and operating income trends plus reaffirmed FY guidance and a major M&A milestone (shareholder approval) create a tradable catalyst mix for INGR.
What to watch
Operating income is down materially year over year on reported and adjusted bases, with specific drivers including impairment/closure costs and Argo plant thermal-event impacts that may not fully normalize immediately.
Ingredion Incorporated Reports Second Quarter 2026 Results
Second-quarter net sales increased 1% and Texture & Healthful Solutions operating income increased 5%, but reported operating income decreased 31%, adjusted operating income decreased 5%, and Food & Industrial Ingredients – U.S./CAN operating income decreased 33%. The company reaffirmed amended full-year EPS guidance while incorporating the sale of a majority stake in the Pakistan business.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total Ingredion net salesother | $1,850 million | – | 1% |
| Total Ingredion net sales change excluding FXother | (1%) | – | – |
| Year-to-date total Ingredion net salesother | $3,642 million | – | —% |
| Year-to-date total Ingredion net sales change excluding FXother | (2%) | – | – |
| Reported operating incomeGAAP | $188 million | – | (31%) |
| Reported operating income change excluding FXGAAP | (32%) | – | – |
| Adjusted operating incomenon-GAAP | $258 million | – | (5%) |
| Adjusted operating income change excluding FXnon-GAAP | (7%) | – | – |
| Year-to-date reported operating incomeGAAP | $391 million | – | (29%) |
| Year-to-date reported operating income change excluding FXGAAP | (31%) | – | – |
| Year-to-date adjusted operating incomenon-GAAP | $470 million | – | (14%) |
| Year-to-date adjusted operating income change excluding FXnon-GAAP | (16%) | – | – |
| Reported diluted EPSGAAP | $1.78 | – | – |
| Adjusted diluted EPSnon-GAAP | $2.82 | – | – |
| Net financing costsGAAP | $55 million | – | – |
| Reported effective tax rateGAAP | 33.7% | – | – |
| Adjusted effective tax ratenon-GAAP | 27.2% | – | – |
| Texture & Healthful Solutions segment operating incomeother | $117 million | – | 5% |
| Food & Industrial Ingredients – LATAM segment operating incomeother | $118 million | – | (7%) |
| Food & Industrial Ingredients – U.S./CAN segment operating incomeother | $58 million | – | (33%) |
| All Other operating income (loss)other | $6 million | – | NM |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Texture & Healthful SolutionsNet sales volume increased $44 million, while price mix decreased $21 million. Segment operating income was driven by volume growth, partially offset by unfavorable price mix and higher tapioca costs. | $627 million | – | 5% |
| Food & Industrial Ingredients – LATAMFavorable foreign exchange contributed $30 million, while volume decreased $5 million and price mix decreased $10 million. Operating income declined primarily due to Mexico’s transactional currency impacts and a more challenging demand environment. | $611 million | – | 3% |
| Food & Industrial Ingredients – U.S./CANVolume decreased $22 million and price mix decreased $13 million. Operating income declined due to lower production at the Argo facility, softer volumes, and price mix; the company said the plant had normalized by the end of the quarter. | $488 million | – | (7%) |
| All OtherVolume increased $3 million and price mix increased $5 million. Operating income increased $7 million from the prior year, reflecting continued improvements in the Protein Fortification business. | $124 million | – | 8% |
full-year 2026 outlook
- Revenueflat to up low single digits
- NoteReported EPS to be in the range of $9.15 to $9.75.
- NoteAdjusted EPS to be in the range of $10.30 to $10.90.
- NoteReported operating income is expected to be down low double digits.
- NoteAdjusted operating income is now expected to be down mid-single digits.
- NoteTexture & Healthful Solutions operating income is now expected to be up mid-to-high single-digits.
- NoteFood & Industrial Ingredients – LATAM operating income is still anticipated to be down low single-digits.
- NoteFood & Industrial Ingredients – U.S./CAN operating income is now expected to be down 20-25%.
- NoteAll Other’s operating loss is now anticipated to be approximately $(15) million.
- NoteCorporate costs for full-year 2026 are now expected to be down mid-single-digits.
Capital returns
- In the second quarter, the Company paid $52 million in dividends to shareholders.
- On May 20, 2026, the Company declared a quarterly dividend of $0.82 per share, which was paid on July 21, 2026.
- Year-to-date, the Company has repurchased $14 million of common stock and remains committed to its $100 million full-year target.
What drove it
- Second-quarter net sales increased 1%, primarily driven by higher net sales volume in Texture & Healthful Solutions and favorable foreign exchange in Food & Industrial Ingredients – LATAM, partially offset by less favorable overall price mix and lower net sales volume in Food & Industrial Ingredients – U.S./CAN.
- Texture & Healthful Solutions delivered its ninth consecutive quarter of broad-based net sales volume growth, driven by strong customer demand for solutions offerings, including clean-label ingredients.
- The difference between reported and adjusted operating income was primarily attributable to impairment charges and costs from the closure of the Cabo, Brazil facility, as well as costs attributable to the previously announced thermal event at the Argo plant.
- The sale of a majority stake in the Pakistan business was completed and is reflected in the amended full-year outlook for the second half of 2026.
- Tate & Lyle shareholders approved Ingredion’s recommended 595 pence all-cash offer on July 28, and Ingredion commenced integration planning work.
Concerns
- Reported operating income decreased 31% and adjusted operating income decreased 5% compared to the second quarter 2025.
- Food & Industrial Ingredients – U.S./CAN operating income decreased 33%, driven by lower production at the Argo facility, softer volumes, and price mix.
- Food & Industrial Ingredients – LATAM operating income decreased 7%, primarily due to Mexico’s transactional currency impacts and a more challenging demand environment.
- Net financing costs included a $47 million mark-to-market foreign exchange loss on derivatives used to hedge British pound sterling exposure related to the pending Tate & Lyle acquisition.
- The reported effective tax rate increased to 33.7% from 23.6%, primarily attributable to the gain on the sale of a majority stake in the Pakistan business and the change in value of the Mexican peso relative to the U.S. dollar.
What to watch
- Texture & Healthful Solutions volume growth and the expected impact of higher input cost inflation on segment operating income.
- Operational execution at the Argo plant after the company reported normal production rates across all major operating units by the end of the quarter.
- Food & Industrial Ingredients – LATAM performance amid Mexican peso strength, transactional currency impacts, and macroeconomic pressures.
- The second-half earnings effect of the sale of a majority stake in the Pakistan business.
- Completion of the pending Tate & Lyle acquisition and integration planning progress.
- Delivery against the $100 million full-year common-stock repurchase target.
Balance sheet and cash flow
- At June 30, 2026, total debt was $1.8 billion, versus $1.8 billion at December 31, 2025.
- At June 30, 2026, cash, including short-term investments, was $952 million, versus $1.0 billion at December 31, 2025.
- Net capital expenditures totaled $210 million through June 30, 2026.
Analysis
Ingredion recorded second-quarter net sales of $1,850 million, up 1% from $1,833 million. The increase reflected higher volume in Texture & Healthful Solutions and favorable foreign exchange in Food & Industrial Ingredients – LATAM, offset partly by less favorable overall price mix and lower volume in Food & Industrial Ingredients – U.S./CAN. On an excluding-FX basis, total net sales decreased 1%.
Profitability weakened materially on a reported basis. Reported operating income was $188 million, down 31% from $271 million, while adjusted operating income was $258 million, down 5% from $273 million. The reported-adjusted difference was primarily tied to impairment charges, Cabo, Brazil closure costs, and costs from the Argo thermal event. Reported diluted EPS was $1.78 versus $2.99, while adjusted diluted EPS was $2.82 versus $2.87. Net financing costs increased to $55 million from $12 million, primarily due to a $47 million mark-to-market foreign exchange loss related to hedging British pound sterling exposure for the pending Tate & Lyle acquisition.
Segment trends were uneven. Texture & Healthful Solutions net sales increased 5% to $627 million and operating income increased 5% to $117 million, supported by volume growth despite unfavorable price mix and higher tapioca costs. Food & Industrial Ingredients – LATAM net sales rose 3% to $611 million, but operating income declined 7% to $118 million amid Mexico transactional currency impacts and a more challenging demand environment. Food & Industrial Ingredients – U.S./CAN net sales declined 7% to $488 million and operating income declined 33% to $58 million, reflecting lower Argo production, softer volumes, and price mix. The company stated that Argo was operating at normal production rates across all major operating units by the end of the quarter.
Capital allocation included $52 million of second-quarter dividends and $14 million of year-to-date common-stock repurchases toward a $100 million full-year target. At June 30, 2026, total debt was $1.8 billion and cash, including short-term investments, was $952 million. Net capital expenditures totaled $210 million through June 30, 2026. Ingredion reaffirmed amended full-year 2026 guidance after reflecting the sale of its majority stake in the Pakistan business, including reported EPS of $9.15 to $9.75 and adjusted EPS of $10.30 to $10.90. The guide calls for adjusted operating income down mid-single digits, while Food & Industrial Ingredients – U.S./CAN operating income is expected to be down 20-25% and Texture & Healthful Solutions operating income is expected to rise mid-to-high single-digits.
Management, verbatim
Ingredion delivered a solid second quarter, with Texture & Healthful Solutions continuing its quarterly net sales volume growth and Food & Industrial Ingredients—U.S./CAN operating results sequentially improving during the quarter.
Jim Zallie, chairman, president and CEO of Ingredion
Texture & Healthful Solutions delivered its ninth consecutive quarter of broad-based net sales volume growth, driven by continued strong customer demand for our solutions offerings, including clean-label ingredients, demonstrating the durability and margin enhancement of our solutions-selling model.
Jim Zallie, chairman, president and CEO of Ingredion
In Food & Industrial Ingredients—U.S./CAN, reliability at our Argo plant improved, with sequentially better production rates, and yields achieved throughout the quarter. We are pleased to say that the plant is operating at normal production rates across all major operating units.
Jim Zallie, chairman, president and CEO of Ingredion
Not in the filing
stated, not guessed- Prior outlook was not provided, so comparisons of reported results with prior guidance are unavailable.
- Gross profit and gross margin were not provided in the filing text supplied.
- Operating expenses were not provided in the filing text supplied.
- GAAP net income and adjusted net income were not provided in the filing text supplied.
- Operating cash flow and free cash flow were not provided in the filing text supplied.
- Prior-quarter comparisons for net sales, operating income, EPS, segment revenue, and segment operating income were not provided.
- The filing text supplied ends during the full-year outlook section, so any guidance following the visible text is unavailable.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
This is an SEC Form 8-K (Item 2.02) with Ingredion’s 2Q26 results and an attached press release, including reaffirmed amended full-year guidance and deal progress commentary.
Ticker impact
Ingredion reported 2Q26 results and reaffirmed full-year EPS guidance, while also noting Tate & Lyle shareholders approved its all-cash acquisition offer.
Likely positive bias as the deal approval reduces transaction uncertainty, but near-term volatility possible given reported EPS decline and operating income pressure.
The 8-K includes specific 2Q26 reported vs adjusted EPS, reaffirmed FY reported/adjusted EPS ranges, and explicit shareholder approval for the Tate & Lyle acquisition, all of which are actionable for positioning.
Market effects
Ingredient suppliers and food/beverage input peers may see read-across on margin durability and integration execution risk.
LATAM and U.S./Canada segment commentary highlights ongoing FX and macro pressure sensitivity for regional ingredient demand.
The Tate & Lyle combination milestone reinforces consolidation in global food ingredient solutions and could affect competitive dynamics internationally.
Counterpoint
Despite shareholder approval, the guidance is reaffirmed with EPS ranges that still reflect prior business-sale effects, so the market may focus on underlying margin and volume trends rather than deal progress.
Key entities
- issuerIngredion Incorporated
Reports 2Q26 results, reaffirms amended FY guidance, and provides updates on the Tate & Lyle acquisition process.
- acquirer_targetTate & Lyle
Its shareholders approved Ingredion’s recommended all-cash offer, a key step toward completing the transaction.
- asset_transactionPakistan business (majority stake sale)
Sale of a majority stake is reflected in the amended full-year guidance ranges Ingredion reaffirmed.
